web analytics

1st International Symposium On Lung-Sparing Therapies For Malignant Pleural Mesothelioma

Main Category: Conferences
Also Included In: Asbestos / Mesothelioma
Article Date: 09 May 2011 – 8:00 PDT

email to a friend   printer friendly   opinions  
<!– rate article

Patient / Public:

Healthcare Prof:

The UCLA Mesothelioma Research
Program is sponsoring the 1st International Symposium on
Lung-Sparing Therapies for Malignant Pleural Mesothelioma
(MPM) at the Sheraton Hotel in Santa Monica, California.
This unique one-day symposium will take place on Saturday,
May 21st from 8:00 a.m. to 5:00 p.m.

The course will be led by Dr. Robert Cameron, MD, FACS,
Director of the Mesothelioma Research Program at the David
Geffen School of Medicine at UCLA, Chief of Thoracic Surgery
at the West Los Angeles Veterans’ Administration Medical
Center, and a long-time advocate for lung-sparing surgery.

The seminar’s distinguished international faculty includes
both Mr. Tom Treasure, MD and Mr. David A Waller, MD, who
will discuss the recent results announced from the
Mesothelioma and Radical Surgery (MARS) Trial conducted in
the U.K. The program will feature additional experts in the
fields of surgery, radiation, chemotherapy and pulmonary
medicine. The symposium was designed primarily for
physicians needing continuing medical education (CME) credit
but other interested parties may attend.

For a brochure on the seminar and to enroll online, go here.

Source:

UCLA Mesothelioma Research Program



981cf lg share en 1st International Symposium On Lung Sparing Therapies For Malignant Pleural Mesothelioma

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care
professional. For more information, please read our terms and conditions.

  Follow us on Twitter
  Conferences headlines
  email to a friend
  printer friendly version
  weekly newsletter
  personalize your news

  back to top


Please note that we publish your name, but we do not publish your email address. It is only used to let
you know when your message is published. We do not use it
for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Privacy Policy |
Terms and Conditions


MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2011 All rights reserved.

Comments are closed.